Sexually Transmitted Diseases Testing Market Size, Share, Growth and Global Industry Analysis By Type & Application, Regional Insights and Forecast to 2024-2032
Growth Factors of Sexually Transmitted Diseases Testing Market
The sexually transmitted diseases testing market size was valued at USD 9.52 billion in 2023 to USD 16.68 billion by 2030, exhibiting a CAGR of 8.3% during the forecast period of 2023-2030.
Due to the reduction in number of reported STD cases during COVID-19 pandemic the market led to reduction in growth. The covid outbreak had a detrimental effect on market growth due to increasing emphasis on covid patients led to reduction in testing of sexually transmitted disease and government imposed social distancing measures during current situation.
Incidence of sexually transmitted diseases is increasing which result in propelling market growth. The demand for medical instruments such as kits are rising from the medical sector boosting sexually transmitted diseases testing market growth during projection period. Some other variables, such as a lack of emphasis on safer sexual intercourse procedures, sharing of sex toys, and sharing of needles or injecting equipment for narcotics or steroids, raise the risk of sexually transmitted diseases fostering sexually transmitted diseases testing market growth. Moreover, industry players are rising emphasis on the release of testing kits is propelling the worldwide sexually transmitted diseases testing market forward. Government is running awareness programs and taking initiatives to create an awareness about sexually transmitted diseases among population promoting market growth.
Additionally, due to global transition from laboratory to point of care testing making the market expand with remarkable growth opportunities. Gradual migration of testing for sexually transmitted diseases from laboratories to point of care will foster the market growth. Providing accurate and prompt diagnosis for patients to receive appropriate treatment and improve health outcomes by reducing the spread of illness is quite difficult, point of care testing is a boon to laboratory testing that can be done in a variety of health care settings including, hospitals, pharmacies, nursing and long-term care facilities.
Comprehensive Analysis of Sexually Transmitted Diseases Testing Market
The sexually transmitted diseases testing market is rising with an exponential rate due to its market versatile segmentation. This market expansion effectively provides a detailed geographical assessment considering the dominant supply and demand forces that impact the sexually transmitted diseases testing management industry. These segmentations are methodically segregated by product types, by application, by setting and by end users. The By Product Type segment include the segmentation such as Instruments and Reagents & Kits, and By Application segment include Genital Herpes, Chlamydia, Syphilis, Human Immunodeficiency Virus, Human Papillomavirus, Gonorrhea and Others, while By Setting segment include Laboratory Testing and Point-of Care. However, By End User segment include Diagnostic Centers, Hospital & Clinics, and Others.
In the sexually transmitted diseases testing market, North America region lead the medical devices market with a market size of USD 3.73 billion in 2022 owing to increasing Incidence of sexually transmitted diseases and global transition from laboratory to point of care testing.
The market's leading companies play an important position in the sexually transmitted diseases testing business, ensuring industrial growth and setting market standards. These prominent market players leading the market include Thermo Fisher Scientific Inc. (U.S.), Bio-Rad Laboratories, Inc. (U.S.), Abbott (U.S.), BD (U.S.), bioMerieux, Inc. (France), Hologic, Inc. (U.S.), F. Hoffmann-La Roche Ltd. (Switzerland), Cepheid (Danaher Corporation) (U.S.) and DiaSorin S.p.A. (Italy) these market players provide a level-playing competitive environment across the globe.
In June 2022, Chembio Diagnostics, Inc. a well-known player in the testing market leads the expansion of the availability of its SURE CHECK HIV Self-Test to national drugstore chains in Brazil and the UK via commerce platforms.
Segmentation Table
ATTRIBUTE DETAILS
Study Period 2019-2030
Base Year 2022
Estimated Year 2023
Forecast Period 2023-2030
Historical Period 2019-2021
Growth Rate CAGR of 8.3% from 2023 to 2030
Unit Value (USD billion)
Segmentation By Product Type, Application, Setting, End User, and Region
By Product Type Instruments
Reagents & Kits
By Application Chlamydia
Syphilis
Genital Herpes
Gonorrhea
Human Immunodeficiency Virus
Human Papillomavirus
Others
By Setting Laboratory Testing
Point-of-Care
By End User Hospital & Clinics
Diagnostic Centers
Others
By Region North America (By Product Type, By Application, By Setting, By End User, By Country)
- U.S.
- Canada
Europe (By Product Type, By Application, By Setting, By End User, By Country/Sub-Region)
- U.K.
- Germany
- France
- Italy
- Spain
- Scandinavia
- Rest of Europe
Asia Pacific (By Product Type, By Application, By Setting, By End User, By Country/Sub-Region)
- Japan
- China
- India
- Australia
- Southeast Asia
- Rest of Asia Pacific
Latin America (By Product Type, By Application, By Setting, By End User, By Country/ Sub-Region)
- Brazil
- Mexico
- Rest of Latin America
Middle East & Africa (By Product Type, By Application, By Setting, By End User, By Country/Sub-Region)
- GCC Countries
- South Africa
- Rest of Middle East & Africa
Please Note: It will take 5-6 business days to complete the report upon order confirmation.
- 1. Introduction
- 1.1. Research Scope
- 1.2. Market Segmentation
- 1.3. Research Methodology
- 1.4. Definitions and Assumptions
- 2. Executive Summary
- 3. Market Dynamics
- 3.1. Market Drivers
- 3.2. Market Restraints
- 3.3. Market Opportunities
- 3.4. Market Trends
- 4. Key Insights
- 4.1. Prevalence of Key Diseases, By Key Countries, 2022
- 4.2. Key Industry Developments
- 4.3. Overview of Regulatory Scenario, By Key Countries/Regions
- 4.4. Technological Advancements in Sexually Transmitted Diseases Testing Market
- 4.5. Impact of COVID-19 on Global Sexually Transmitted Diseases Testing Market
- 5. Global Sexually Transmitted Diseases Testing Market Analysis, Insights and Forecast, 2019-2030
- 5.1. Market Analysis, Insights and Forecast – By Product Type
- 5.1.1. Instruments
- 5.1.2. Reagents & Kits
- 5.2. Market Analysis, Insights and Forecast – By Application
- 5.2.1. Chlamydia
- 5.2.2. Syphilis
- 5.2.3. Genital Herpes
- 5.2.4. Gonorrhea
- 5.2.5. Human Immunodeficiency Virus
- 5.2.6. Human Papillomavirus (HPV)
- 5.2.7. Others
- 5.3. Market Analysis, Insights and Forecast – By Setting
- 5.3.1. Laboratory Testing
- 5.3.2. Point-of Care (POC)
- 5.4. Market Analysis, Insights and Forecast – By End User
- 5.4.1. Hospitals and Clinics
- 5.4.2. Diagnostic Centers
- 5.4.3. Others
- 5.5. Market Analysis, Insights and Forecast – By Region
- 5.5.1. North America
- 5.5.2. Europe
- 5.5.3. Asia Pacific
- 5.5.4. Latin America
- 5.5.5. Middle East & Africa
- 6. North America Sexually Transmitted Diseases Testing Market Analysis, Insights and Forecast, 2019-2030
- 6.1. Market Analysis, Insights and Forecast – By Product Type
- 6.1.1. Instruments
- 6.1.2. Reagents & Kits
- 6.2. Market Analysis, Insights and Forecast – By Application
- 6.2.1. Chlamydia
- 6.2.2. Syphilis
- 6.2.3. Genital Herpes
- 6.2.4. Gonorrhea
- 6.2.5. Human Immunodeficiency Virus
- 6.2.6. Human Papillomavirus (HPV)
- 6.2.7. Others
- 6.3. Market Analysis, Insights and Forecast – By Setting
- 6.3.1. Laboratory Testing
- 6.3.2. Point-of Care (POC)
- 6.4. Market Analysis, Insights and Forecast – By End User
- 6.4.1. Hospitals and Clinics
- 6.4.2. Diagnostic Centers
- 6.4.3. Others
- 6.5. Market Analysis, Insights and Forecast – By Country
- 6.5.1. U.S.
- 6.5.2. Canada
- 7. Europe Sexually Transmitted Diseases Testing Market Analysis, Insights and Forecast, 2019-2030
- 7.1. Market Analysis, Insights and Forecast – By Product Type
- 7.1.1. Instruments
- 7.1.2. Reagents & Kits
- 7.2. Market Analysis, Insights and Forecast – By Application
- 7.2.1. Chlamydia
- 7.2.2. Syphilis
- 7.2.3. Genital Herpes
- 7.2.4. Gonorrhea
- 7.2.5. Human Immunodeficiency Virus
- 7.2.6. Human Papillomavirus (HPV)
- 7.2.7. Others
- 7.3. Market Analysis, Insights and Forecast – By Setting
- 7.3.1. Laboratory Testing
- 7.3.2. Point-of Care (POC)
- 7.4. Market Analysis, Insights and Forecast – By End User
- 7.4.1. Hospitals and Clinics
- 7.4.2. Diagnostic Centers
- 7.4.3. Others
- 7.5. Market Analysis, Insights and Forecast – By Country/ Sub-Region
- 7.5.1. U.K
- 7.5.2. Germany
- 7.5.3. France
- 7.5.4. Italy
- 7.5.5. Spain
- 7.5.6. Scandinavia
- 7.5.7. Rest of Europe
- 8. Asia Pacific Sexually Transmitted Diseases Testing Market Analysis, Insights and Forecast, 2019-2030
- 8.1. Market Analysis, Insights and Forecast – By Product Type
- 8.1.1. Instruments
- 8.1.2. Reagents & Kits
- 8.2. Market Analysis, Insights and Forecast – By Application
- 8.2.1. Chlamydia
- 8.2.2. Syphilis
- 8.2.3. Genital Herpes
- 8.2.4. Gonorrhea
- 8.2.5. Human Immunodeficiency Virus
- 8.2.6. Human Papillomavirus (HPV)
- 8.2.7. Others
- 8.3. Market Analysis, Insights and Forecast – By Setting
- 8.3.1. Laboratory Testing
- 8.3.2. Point-of Care (POC)
- 8.4. Market Analysis, Insights and Forecast – By End User
- 8.4.1. Hospitals and Clinics
- 8.4.2. Diagnostic Centers
- 8.4.3. Others
- 8.5. Market Analysis, Insights and Forecast – By Country/ Sub-Region
- 8.5.1. Japan
- 8.5.2. China
- 8.5.3. India
- 8.5.4. Australia
- 8.5.5. Southeast Asia
- 8.5.6. Rest of Asia Pacific
- 9. Latin America Sexually Transmitted Diseases Testing Market Analysis, Insights and Forecast, 2019-2030
- 9.1. Market Analysis, Insights and Forecast – By Product Type
- 9.1.1. Instruments
- 9.1.2. Reagents & Kits
- 9.2. Market Analysis, Insights and Forecast – By Application
- 9.2.1. Chlamydia
- 9.2.2. Syphilis
- 9.2.3. Genital Herpes
- 9.2.4. Gonorrhea
- 9.2.5. Human Immunodeficiency Virus
- 9.2.6. Human Papillomavirus (HPV)
- 9.2.7. Others
- 9.3. Market Analysis, Insights and Forecast – By Setting
- 9.3.1. Laboratory Testing
- 9.3.2. Point-of Care (POC)
- 9.4. Market Analysis, Insights and Forecast – By End User
- 9.4.1. Hospitals and Clinics
- 9.4.2. Diagnostic Centers
- 9.4.3. Others
- 9.5. Market Analysis, Insights and Forecast – By Country/ Sub-Region
- 9.5.1. Brazil
- 9.5.2. Mexico
- 9.5.3. Rest of Latin America
- 10. Middle East & Africa Sexually Transmitted Diseases Testing Market Analysis, Insights and Forecast, 2019-2030
- 10.1. Market Analysis, Insights and Forecast – By Product Type
- 10.1.1. Instruments
- 10.1.2. Reagents & Kits
- 10.2. Market Analysis, Insights and Forecast – By Application
- 10.2.1. Chlamydia
- 10.2.2. Syphilis
- 10.2.3. Genital Herpes
- 10.2.4. Gonorrhea
- 10.2.5. Human Immunodeficiency Virus
- 10.2.6. Human Papillomavirus (HPV)
- 10.2.7. Others
- 10.3. Market Analysis, Insights and Forecast – By Setting
- 10.3.1. Laboratory Testing
- 10.3.2. Point-of Care (POC)
- 10.4. Market Analysis, Insights and Forecast – By End User
- 10.4.1. Hospitals and Clinics
- 10.4.2. Diagnostic Centers
- 10.4.3. Others
- 10.5. Market Analysis, Insights and Forecast – By Country/ Sub-Region
- 10.5.1. GCC
- 10.5.2. South Africa
- 10.5.3. Rest of Middle East & Africa
- 11. Competitive Analysis
- 11.1. Global Market Share Analysis (2022)
- 11.2. Company Profiles (Overview, Product, SWOT Analysis, Recent Developments, Strategies, financials (Based on Availability))
- 11.2.1. Abbott
- 11.2.1.1. Overview,
- 11.2.1.2. Product,
- 11.2.1.3. SWOT Analysis,
- 11.2.1.4. Recent Developments,
- 11.2.1.5. Strategies,
- 11.2.1.6. financials (Based on Availability)
- 11.2.2. F. Hoffmann-La Roche Ltd
- 11.2.2.1. Overview,
- 11.2.2.2. Product,
- 11.2.2.3. SWOT Analysis,
- 11.2.2.4. Recent Developments,
- 11.2.2.5. Strategies,
- 11.2.2.6. financials (Based on Availability)
- 11.2.3. Becton, Dickinson and Company (BD)
- 11.2.3.1. Overview,
- 11.2.3.2. Product,
- 11.2.3.3. SWOT Analysis,
- 11.2.3.4. Recent Developments,
- 11.2.3.5. Strategies,
- 11.2.3.6. financials (Based on Availability)
- 11.2.4. Hologic, Inc.
- 11.2.4.1. Overview,
- 11.2.4.2. Product,
- 11.2.4.3. SWOT Analysis,
- 11.2.4.4. Recent Developments,
- 11.2.4.5. Strategies,
- 11.2.4.6. financials (Based on Availability)
- 11.2.5. Danaher Corporation
- 11.2.5.1. Overview,
- 11.2.5.2. Product,
- 11.2.5.3. SWOT Analysis,
- 11.2.5.4. Recent Developments,
- 11.2.5.5. Strategies,
- 11.2.5.6. financials (Based on Availability)
- 11.2.6. Thermo Fisher Scientific Inc.
- 11.2.6.1. Overview,
- 11.2.6.2. Product,
- 11.2.6.3. SWOT Analysis,
- 11.2.6.4. Recent Developments,
- 11.2.6.5. Strategies,
- 11.2.6.6. financials (Based on Availability)
- 11.2.7. bioMérieux, Inc.
- 11.2.7.1. Overview,
- 11.2.7.2. Product,
- 11.2.7.3. SWOT Analysis,
- 11.2.7.4. Recent Developments,
- 11.2.7.5. Strategies,
- 11.2.7.6. financials (Based on Availability)
- 11.2.8. Bio-Rad Laboratories, Inc.
- 11.2.8.1. Overview,
- 11.2.8.2. Product,
- 11.2.8.3. SWOT Analysis,
- 11.2.8.4. Recent Developments,
- 11.2.8.5. Strategies,
- 11.2.8.6. financials (Based on Availability)
- 11.2.9. DiaSorin Inc.
- 11.2.9.1. Overview,
- 11.2.9.2. Product,
- 11.2.9.3. SWOT Analysis,
- 11.2.9.4. Recent Developments,
- 11.2.9.5. Strategies,
- 11.2.9.6. financials (Based on Availability)
Research Assistance
Download our eBook: How to Succeed Using Market Research
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook